封面
市场调查报告书
商品编码
1467626

2024-2032 年按产品类型、技术、疾病、最终用户和地区分類的组织诊断市场报告

Tissue Diagnostics Market Report by Product Type, Technology, Disease, End-User, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2023 年,全球IMARC Group诊断市场规模达到 55 亿美元。

组织诊断包括透过捕获疾病的生物学背景来分析和测试特定组织样本。它们用于检测某些医疗状况,如癌症和发炎性疾病,并揭示恶性肿瘤的确切类型和程度,这有助于确定潜在的原因和治疗方案。组织诊断非常准确、廉价,并且可以透过核心活检和开放活检等不同技术进行。如今,免疫组织化学(IHC)、原位杂交(ISH)、数位病理学和特殊染色等先进技术也被用于进行这些诊断。

由于生育率下降和预期寿命延长,目前全球老年人口的整体比例正在稳步增长。这是促进市场成长的关键因素,因为老年人更容易患慢性病,因此需要经常检查和诊断。除此之外,饮食模式的改变、饮酒量的增加以及个体体力活动的减少导致了多种生活方式疾病的发生率上升。除此之外,各年龄层各种癌症盛行率的上升也导致这些诊断服务的需求激增。

本报告回答的关键问题

  • 全球组织诊断市场有多大?
  • 2024-2032年全球组织诊断市场的预期成长率是多少?
  • 推动全球组织诊断市场的关键因素是什么?
  • COVID-19 对全球组织诊断市场有何影响?
  • 根据产品类型,全球组织诊断市场的细分如何?
  • 基于该技术的全球组织诊断市场的细分情况如何?
  • 基于该疾病的全球组织诊断市场的细分是什么?
  • 基于最终用户的全球组织诊断市场的细分情况如何?
  • 全球组织诊断市场的关键区域有哪些?
  • 谁是全球组织诊断市场的主要参与者/公司?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球组织诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔:依产品类型
  • 市场区隔:按技术
  • 市场区隔:依疾病分类
  • 市场区隔:按最终用户
  • 市场区隔:按地区
  • 市场预测

第 6 章:市场区隔:依产品类型

  • 仪器
    • 市场走向
    • 市场预测
  • 耗材
    • 市场走向
    • 市场预测

第 7 章:市场区隔:依技术

  • 免疫组织化学
    • 市场走向
    • 市场预测
  • 原位杂交
    • 市场走向
    • 市场预测
  • 数位病理学和工作流程管理
    • 市场走向
    • 市场预测
  • 特殊染色
    • 市场走向
    • 市场预测

第 8 章:市场区隔:依疾病分类

  • 乳癌
    • 市场走向
    • 市场预测
  • 胃癌
    • 市场走向
    • 市场预测
  • 淋巴瘤
    • 市场走向
    • 市场预测
  • 摄护腺癌
    • 市场走向
    • 市场预测
  • 非小细胞肺癌
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章:市场区隔:按最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 研究实验室
    • 市场走向
    • 市场预测
  • 製药公司
    • 市场走向
    • 市场预测
  • 合约研究组织
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章:市场区隔:按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 11 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章:价值链分析

第 13 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章:价格分析

  • 价格指标
  • 价格结构
  • 利润分析

第15章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Roche
    • Danaher
    • Thermo Fisher Scientific
    • Abbott
    • Agilent Technologies
    • Merck
    • Sakura Finetek Japan
    • Abcam
    • BD
    • Qiagen
    • Bio SB
    • Biogenex
    • Cell Signaling Technology
Product Code: SR112024A1349

The global tissue diagnostics market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, technology, disease and end-user.

Breakup by Product Type:

Instruments

Consumables

Breakup by Technology:

Immunohistochemistry

In Situ Hybridization

Digital Pathology and Workflow Management

Special Staining

Breakup by Disease:

Breast Cancer

Gastric Cancer

Lymphoma

Prostate Cancer

Non-Small Cell Lung Cancer

Others

Breakup by End-User:

Hospitals

Research Laboratories

Pharmaceutical Companies

Contract Research Organizations

Others

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Key Questions Answered in This Report

  • 1. How big is the global tissue diagnostics market?
  • 2. What is the expected growth rate of the global tissue diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global tissue diagnostics market?
  • 4. What has been the impact of COVID-19 on the global tissue diagnostics market?
  • 5. What is the breakup of the global tissue diagnostics market based on the product type?
  • 6. What is the breakup of the global tissue diagnostics market based on the technology?
  • 7. What is the breakup of the global tissue diagnostics market based on the disease?
  • 8. What is the breakup of the global tissue diagnostics market based on the end-user?
  • 9. What are the key regions in the global tissue diagnostics market?
  • 10. Who are the key players/companies in the global tissue diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunohistochemistry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 In Situ Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Digital Pathology and Workflow Management
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Special Staining
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Breast Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastric Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lymphoma
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Non-Small Cell Lung Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Contract Research Organizations
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Roche
    • 15.3.2 Danaher
    • 15.3.3 Thermo Fisher Scientific
    • 15.3.4 Abbott
    • 15.3.5 Agilent Technologies
    • 15.3.6 Merck
    • 15.3.7 Sakura Finetek Japan
    • 15.3.8 Abcam
    • 15.3.9 BD
    • 15.3.10 Qiagen
    • 15.3.11 Bio SB
    • 15.3.12 Biogenex
    • 15.3.13 Cell Signaling Technology

List of Figures

  • Figure 1: Global: Tissue Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Tissue Diagnostics Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Tissue Diagnostics Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Tissue Diagnostics Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Tissue Diagnostics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Tissue Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Tissue Diagnostics Industry: SWOT Analysis
  • Figure 9: Global: Tissue Diagnostics Industry: Value Chain Analysis
  • Figure 10: Global: Tissue Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Tissue Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 12: Global: Tissue Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Tissue Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Tissue Diagnostics (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Tissue Diagnostics (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Tissue Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Tissue Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Tissue Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Tissue Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Tissue Diagnostics (Special Staining) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Tissue Diagnostics (Special Staining) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Tissue Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Tissue Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Tissue Diagnostics (Gastric Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Tissue Diagnostics (Gastric Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Tissue Diagnostics (Lymphoma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Tissue Diagnostics (Lymphoma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Tissue Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Tissue Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Tissue Diagnostics (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Tissue Diagnostics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Tissue Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Tissue Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Tissue Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Tissue Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Tissue Diagnostics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Tissue Diagnostics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Tissue Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Tissue Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Tissue Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Tissue Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: North America: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: North America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia Pacific: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia Pacific: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Middle East and Africa: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Middle East and Africa: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Latin America: Tissue Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Latin America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Tissue Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Tissue Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Tissue Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Tissue Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 5: Global: Tissue Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Tissue Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Tissue Diagnostics Market Structure
  • Table 8: Global: Tissue Diagnostics Market: Key Players